Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Takeda Pharmaceutical has acquired an exclusive global license, worth up to $420 million, from Chicago-based COUR Pharmaceutical Development Company for developing and commercializing an investigational medicine for treating celiac disease. The...

Novo Nordisk and Bluebird Bio, a developer of gene therapies for severe genetic diseases and cancer, have entered into a three-year research collaboration to jointly develop in vivo genome-editing treatments for genetic diseases, including...

The UK’s Centre for Process Innovation (CPI), the UK government’s process manufacturing arm of Catapult centers that are designed to encourage innovation, has begun work on a project to develop a continuous direct compression (CDC) platform for...

Alexion Pharmaceuticals, a Boston, Massachusetts-based pharmaceutical company focused on rare diseases, has agreed to acquire Achillion Pharmaceuticals, a Blue Bell, Pennsylvania-based clinical-stage biopharmaceutical company focused on developing...

UCB has agreed to acquire Ra Pharmaceuticals, a clinical-stage biopharmaceutical company focused on therapies for rare diseases, for a total transaction value of approximately $2.1 billion. Under the agreement, Ra Pharma shareholders will receive...

GlaxoSmithKline (GSK) has formed a five-year collaboration with Lyell Immunopharma, a San Francisco-based adoptive cell therapy biotechnology company, to develop new technologies for cell therapies for treating solid tumors. The collaboration will...